
Anna Donaghey addresses listener questions about the impact of Mounjaro on alcohol cravings and the importance of understanding one's relationship with alcohol.
"I'm drinking less on Mounjaro, should I see this as a win?" It's a question landing in Anna Donaghey's inbox more and more, and in this listener Q&A episode, she gives it the thoughtful answer it deserves. Medications like Mounjaro, originally prescribed for diabetes and weight management, are quietly dialling down people's desire for alcohol often without them even trying. Anna explores what the emerging research tells us about GLP-1 drugs and the brain's reward system, why the effect on cravings may not last, and why it's so important not to skip the deeper work of understanding your relationship with alcohol, even when the urge has gone dormant. Because here's the real opportunity: this "hiatus of desire" is a rare window for self-enquiry, not a shortcut. Anna shares her perspective on the risks of treating pharmaceuticals as a simple fix, and offers practical reflection prompts for anyone noticing their cravings have changed. If your desire to drink has suddenly gone quiet, this episode will help you ask the question that really matters: what was it saying in the first place? Here are the Highlights: 00:00 Intro: The rise of questions about Mounjaro and drinking 01:05…
Explore listener stats, chart rankings, contacts and more on the The Big Drink Rethink podcast page.